Histology and Cytology Market: Current Analysis and Forecast (2022-2030)

Histology and cytology are interconnected areas of study that center on examining tissues and cells to detect medical conditions and anomalies. The histology sector focuses on readying, coloring, and scrutinizing samples of tissues to identify ailments like cancer. In contrast, cytology focuses on analyzing individual cells to pinpoint any irregularities or malignant cells.

The Histology And Cytology Market is expected to grow at a strong CAGR of 12.4% during the forecast period owing to the increasing prevalence of cancer and the growing aging population. Moreover, numerous governments worldwide have initiated campaigns to encourage cancer screening and early detection, which is anticipated to fuel the demand for histology and cytology techniques. For example, the US administration has introduced the Early Detection Research Network (EDRN) under the National Cancer Institute to encourage the timely detection of cancer using biomarkers and other diagnostic methods.

Based on examination type, the histology and cytology market is segmented into histology and cytology (Breast Cancer, Cervical Cancer, and Others). The cytology segment accounted for a significant market share in 2021 and it is estimated to grow rapidly during the projected timeframe. This is mainly owing to cytology tests being widely used for cellular-level observations in the identification of various cancer kinds, such as breast and cervical cancer coupled with the growing popularity of co-testing across the globe. For instance, in Mar 2020, Roche received FDA approval for the CINtec PLUS Cytology test to aid clinicians in improving cervical cancer prevention.

Based on test type, the histology and cytology market is divided into microscopy tests, molecular genetics tests, and flow cytometry. Among these, microscopy tests will attain a considerable share of the market during the forecast period. Microscopy tests are utilized for the purpose of scrutinizing tissue samples under a microscope to identify irregularities or diagnose diseases. These tests have gained widespread popularity and are considered an established and efficient diagnostic tool that is utilized in numerous medical fields.

Based on product type, the histology and cytology market is segmented into Instruments & Analysis Software System, and Consumable & Reagents. Among these, consumable and reagents segment accounted for a significant market share in 2021 and estimated to grow rapidly during the forecast period. The rising incidence of cancer and chronic diseases has led to an increase in demand for histology and cytology tests, which in turn has driven the growth of consumables and reagents. In addition, the shift towards personalized medicine has led to an increase in demand for molecular diagnostics and genetic testing, which require a wide range of consumables and reagents.

Based on end-user, the market is segmented into Hospitals & Clinical Diagnostics, Academic & Research Institutes, and Others. Clinical Diagnostics are expected to grow at a substantial CAGR during the forecasted period. As the application of histopathology studies for diagnosing various types of cancer has been on the rise, the removal of cells and tissues from suspected lumps for the purpose of identifying abnormalities and malignancies has become prevalent. These studies are extensively utilized for the screening of several types of cancer, including breast, bowel, and cervical cancer.

For a better understanding of the market adoption of the Industrial Relay industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain , Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Rest of World. North America is expected to lead the market share owing to the factors such as the increase in the number of research and development activities, product approvals, and commercialization, as well as the prevalence of geriatrics in the area. Additionally, the region has seen a high prevalence of cancer and a rising number of older adults who are affected which in turn increases the growth of the market. According to the American Cancer Society, Inc., the estimated number of new cancer cases and deaths in 2021 (In 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States.)

Some of the major players operating in the market include: Abbott; BD, Merck KGaA, F. Hoffmann-La Roche Ltd; Hologic, Inc.; Sysmex Corporation; Danaher; Trivitron Healthcare; Thermo Fisher Scientific Inc; Agilent Technologies, Inc.